Skip to content

Long-shaft Vitrectomy Probe in Highly Myopic Eyes

The Surgical Outcomes of Long-shaft Vitrectomy Probe for Vitreoretinal Diseases in Highly Myopic Eyes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04902170
Enrollment
86
Registered
2021-05-26
Start date
2021-07-22
Completion date
2023-02-07
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Myopia, Retinal Diseases

Keywords

High myopia, Pars plana vitrectomy, Vitreoretinal disease

Brief summary

This study aimed to compare the safety and efficacy of vitrectomy probe with different shaft lengths in vitreoretinal surgery of highly myopic patients. In this randomized controlled study, highly myopic patients who had axial length more than 26 mm and needed vitreoretinal surgery will be enrolled. The enrolled patients will be randomized into 30 mm shaft length group(trial group) and 27mm shaft length group(controlled group). We will compare the rate of wound leakage, hypotony, subconjunctival hemorrhage, probe bending, trocar removal, and endophthalmitis between the two groups. We would like to evaluate the efficacy and safety of the 30 mm shaft length vitrectomy probe.

Interventions

PROCEDURE25 gauge pars plana vitrectomy

25 gauge pars plana vitrectomy

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Highly myopic patients (axial length \> 26mm) with vitreoretinal diseases or maculopathy requiring pars plana vitrectomy

Exclusion criteria

* Previous history of pars plana vitrectomy * Surgical plan combining encircling buckle * Silicone oil or perfluorocarbon liquid use intraoperatively * Previous history of pterygium surgery, trabeculectomy, glaucoma surgery * Previous history of corneal, conjunctival, or scleral laceration * History of connective tissue disease

Design outcomes

Primary

MeasureTime frameDescription
trocar removal rateintra-operativetrocar removal would be performed if the length of vitrectomy probe was not adequate
operation timeintra-operativerecord the operation time and time of core vitrectomy

Secondary

MeasureTime frameDescription
instrument bendingintraoperativerecord the occurrence of instrument bending

Other

MeasureTime frameDescription
ComplicationsUntil post-op 6 monththe presence of vitreous hemorrhage, retinal hemorrhage, retinal detachment, choroidal hemorrhage, endophthalmitis
wound status evaluation by slit lamp biomicroscopyuntil post-op 1 monththe presence of subconjunctival hemorrhage, chemosis, subconjunctival air, wound suture
anatomical success evaluation by optical coherence tomography and indirect ophthalmolscopypost-op 3 monthwhether the disease was successfully treated

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026